UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development and Validation of a Noninvasive Method to Determine Arterial Pressure and Vascular Compliance

The American journal of cardiology, 1997-08, Vol.80 (3), p.323-330

1997

Volltextzugriff (PDF)

Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity

Hypertension (Dallas, Tex. 1979), 2000-11, Vol.36 (5), p.878-884

2000

Volltextzugriff (PDF)

Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension

Hypertension (Dallas, Tex. 1979), 1995-07, Vol.26 (1), p.143-149

1995

Volltextzugriff (PDF)

Arterial Compliance by Cuff Sphygmomanometer: Application to Hypertension and Early Changes in Subjects at Genetic Risk

Hypertension (Dallas, Tex. 1979), 1996-10, Vol.28 (4), p.599-603

1996

Volltextzugriff (PDF)

Racial differences in renal kallikrein excretion: Effect of the ovulatory cycle

Kidney international, 1998-11, Vol.54 (5), p.1652-1658

1998

Volltextzugriff (PDF)

Chromogranin A in human disease

Advances in experimental medicine and biology, 2000, Vol.482, p.377

2000

Volltextzugriff (PDF)

Complex trait genetics: new methods yield a result for essential hypertension

The Journal of clinical investigation, 1996-05, Vol.97 (9), p.1997-1998

1996

Volltextzugriff (PDF)

Factitious pheochromocytoma: Novel mimickry by valsalva maneuver and clues to diagnosis

American journal of hypertension, 1995-06, Vol.8 (6), p.651-655

1995

Volltextzugriff (PDF)

Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertension

Journal of human hypertension, 1994-07, Vol.8 (7), p.515

1994

Volltextzugriff (PDF)

Chromogranin A in Human Hypertension: Influence of Heredity

Hypertension (Dallas, Tex. 1979), 1995-07, Vol.26 (1), p.213-220

1995

Volltextzugriff (PDF)

Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk

Journal of hypertension, 2000-11, Vol.18 (11), p.1611-1620

2000

Volltextzugriff (PDF)

Early Alteration in Glomerular Reserve in Humans at Genetic Risk of Essential Hypertension: Mechanisms and Consequences

Hypertension (Dallas, Tex. 1979), 2001-03, Vol.37 (3), p.898-906

2001

Volltextzugriff (PDF)

Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms

The Journal of pharmacology and experimental therapeutics, 1999-11, Vol.291 (2), p.793

1999

Volltextzugriff (PDF)

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

Journal of hypertension, 2002-07, Vol.20 (7), p.1335-1345

2002

Volltextzugriff (PDF)

Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia

Neurobiology of aging, 1993-05, Vol.14 (3), p.267-269

1993

Volltextzugriff (PDF)

Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?

Journal of hypertension, 1994-11, Vol.12 (11), p.1243-1248

1994

Volltextzugriff (PDF)

β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

American journal of hypertension, 2000-09, Vol.13 (9), p.1021-1026

2000

Volltextzugriff (PDF)

Human sympathetic activation by α -adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism

Clinical pharmacology and therapeutics, 2004-08, Vol.76 (2), p.139-153

2004

Volltextzugriff (PDF)

Expression of altered α2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension

Journal of hypertension, 1998-06, Vol.16 (6), p.779-792

1998

Volltextzugriff (PDF)

Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension

American journal of hypertension, 2003-04, Vol.16 (4), p.281-289

2003

Volltextzugriff (PDF)

β -adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

American journal of hypertension, 2000-09, Vol.13 (9), p.1021-1026

2000

Volltextzugriff (PDF)

The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension

Annals of the New York Academy of Sciences, 2002-10, Vol.971 (1), p.533-535

2002

Volltextzugriff (PDF)

Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

American journal of hypertension, 2000-09, Vol.13 (9), p.1021

2000

Volltextzugriff (PDF)

2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

American journal of hypertension, 2000-09, Vol.13 (9), p.1021-1026

2000

Volltextzugriff (PDF)

Hereditary intermediate phenotypes in African American hypertension

Ethnicity & health, 1996-05, Vol.1 (2), p.117-128

1996

Volltextzugriff (PDF)

1 – 25 von 276

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(217)

Publikationsform

Sprache

Englisch
(275)
Japanisch
(13)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Development and Validation of a Noninvasive Method to Determine Arterial Pressure and Vascular Compliance

Plasma Hydrogen Peroxide Production in Human Essential Hypertension: Role of Heredity, Gender, and Ethnicity

Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension

Arterial Compliance by Cuff Sphygmomanometer: Application to Hypertension and Early Changes in Subjects at Genetic Risk

Racial differences in renal kallikrein excretion: Effect of the ovulatory cycle

Chromogranin A in human disease

Complex trait genetics: new methods yield a result for essential hypertension

Factitious pheochromocytoma: Novel mimickry by valsalva maneuver and clues to diagnosis

Effects of an oral prostaglandin E1 agonist on blood pressure and its determinants in essential hypertension

Chromogranin A in Human Hypertension: Influence of Heredity

Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk

Early Alteration in Glomerular Reserve in Humans at Genetic Risk of Essential Hypertension: Mechanisms and Consequences

Variability in phenylephrine response and essential hypertension: a search for human alpha(1B)-adrenergic receptor polymorphisms

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia

Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?

β2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

Human sympathetic activation by α -adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism

Expression of altered α2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension

Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension

β -adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension

Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans

Hereditary intermediate phenotypes in African American hypertension

Suchergebnisse filtern